Objective: Anxiety symptoms are common in older adults with depression, but whether severe anxiety is associated with poorer outcomes of depression is unknown. The objective of the present study was to examine the association between severity of anxiety and severity of depression and physical illness, suicidality, and physical and cognitive functioning in older adults with depression. Methods: We included 218 older adults with diagnoses of a depressive disorder according to the ICD-10 criteria; their mean age (SD) was 75.6 (7.2), and 67.0% were women. The Geriatric Anxiety Inventory (GAI) was used to measure the severity of anxiety symptoms. The Montgomery-Aasberg Depression Rating Scale (MADRS) was used to assess the severity of depression. We obtained information on the level of functioning with the Physical Self-Maintenance Scale (PSMS) by Lawton and Brody and on cognition with the Mini-Mental State Examination (MMSE) and the Clock-Drawing Test (CDT). Physical health was determined based on information regarding falls and weight loss and an assessment of each patient’s general medical condition. The treating physician evaluated current suicidality in a comprehensive and standardized way. Results: Higher GAI scores were significantly associated with scores on the MADRS (β = 0.233, p = 0.002) and suicidality (β = 0.206, p = 0.006). Levels of physical or cognitive functioning were not associated with the GAI score. Conclusion: The severity of anxiety symptoms was associated with the severity of depression and suicidality in older adults with depressive disorders. The results could indicate a need to focus greater attention on the treatment of anxiety and suicidality in older patients with depression.

1.
Byrne GJ, Pachana NA: Anxiety and depression in the elderly: do we know any more? Curr Opin Psychiatry 2010; 23: 504–509.
2.
Bendixen AB, Engedal K: Anxiety among older psychiatric patients: a hidden comorbidity? Aging Ment Health 2016; 20: 1131–1138.
3.
lmeida OP, Draper B, Pirkis J, Snowdon J, Lautenschlager NT, Byrne G, Sim M, Stocks N, Kerse N, Flicker L, Pfaff JJ: Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years. Int Psychogeriatr 2012; 24: 1622–1632.
4.
Schoevers RA, Beekman AT, Deeg DJ, Jonker C, Tilburg W: Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry 2003; 18: 994–1001.
5.
Skoog I: Psychiatric disorders in the elderly. Can J Psychiatry 2011; 56: 387–397.
6.
Lenze EJ, Wetherell JL: A lifespan view of anxiety disorders. Dialogues Clin Neurosci 2011; 13: 381–399.
7.
Brodaty H, Pachana NA: Through a glass, only slightly less darkly: advances in measuring the influences of late-life anxiety. Am J Geriatr Psychiatry 2014; 22: 1379–1381.
8.
Steffens DC, McQuoid DR: Impact of symptoms of generalized anxiety disorder on the course of late-life depression. Am J Geriatr Psychiatry 2005; 13: 40–47.
9.
Nelson JC, Delucchi K, Schneider LS: Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. Int J Geriatr Psychiatry 2009; 24: 539–544.
10.
Pawlak J, Dmitrzak-Weglarz M, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Rajewska-Rager A, Zaremba D, Czerski P, Hauser J: Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders. Gen Hosp Psychiatry 2013; 35: 427–432.
11.
Almeida OP, Pirkis J, Kerse N, Sim M, Flicker L, Snowdon J, Draper B, Byrne G, Goldney R, Lautenschlager NT, Stocks N, Alfonso H, Pfaff JJ: A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients. Ann Fam Med 2012; 10: 347–356.
12.
Waern M, Runeson BS, Allebeck P, Beskow J, Rubenowitz E, Skoog I, Wilhelmsson K: Mental disorder in elderly suicides: a case-control study. Am J Psychiatry 2002; 159: 450–455.
13.
Conwell Y, Duberstein PR, Hirsch JK, Conner KR, Eberly S, Caine ED: Health status and suicide in the second half of life. Int J Geriatr Psychiatry 2010; 25: 371–379.
14.
Kjolseth I, Ekeberg O, Steihaug S: Why suicide? Elderly people who committed suicide and their experience of life in the period before their death. Int Psychogeriatr 2010; 22: 209–218.
15.
Kjolseth I, Ekeberg O, Steihaug S: “Why do they become vulnerable when faced with the challenges of old age?” Elderly people who committed suicide, described by those who knew them. Int Psychogeriatr 2009; 21: 903–912.
16.
Andreescu C, Varon D: New research on anxiety disorders in the elderly and an update on evidence-based treatments. Curr Psychiatry Rep 2015; 17: 53.
17.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146–M156.
18.
Ni Mhaolain AM, Fan CW, Romero-Ortuno R, Cogan L, Cunningham C, Kenny R-A, Lawlor B: Frailty, depression, and anxiety in later life. Int Psychogeriatr 2012; 24: 1265–1274.
19.
Uchmanowicz I, Gobbens R: The relationship between frailty, anxiety and depression, and health-related quality of life in elderly patients with heart failure. Clin Interv Aging 2015; 10: 1595–1600.
20.
Tully PJ, Harrison NJ, Cheung P, Cosh S: Anxiety and cardiovascular disease risk: a review. Curr Cardiol Rep 2016; 18: 120.
21.
Blyth FM, Cumming RG, Nicholas MK, Creasey H, Handelsman DJ, Le Couteur DG, Naganathan V, Sambrook PN, Seibel MJ, Waite LM: Intrusive pain and worry about health in older men: the CHAMP study. Pain 2011; 152: 447–452.
22.
Young WR, Olonilua M, Masters RS, Dimitriadis S, Mark Williams A: Examining links between anxiety, reinvestment and walking when talking by older adults during adaptive gait. Exp Brain Res 2016; 234: 161–172.
23.
Simning A, Conwell Y, Mohile SG, van Wijngaarden E: The moderating effect of age on the 12-month prevalence of anxiety and depressive disorders in adults with a lifetime history of cancer. Am J Geriatr Psychiatry 2014; 22: 1399–1409.
24.
Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG: The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 2013; 21: 685–695.
25.
Rozzini L, Chilovi BV, Peli M, Conti M, Rozzini R, Trabucchi M, Padovani A: Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry 2009; 24: 300–305.
26.
Balash Y, Mordechovich M, Shabtai H, Giladi N, Gurevich T, Korczyn AD: Subjective memory complaints in elders: depression, anxiety, or cognitive decline? Acta Neurol Scand 2013; 127: 344–350.
27.
de Bruijn RF, Direk N, Mirza SS, Hofman A, Koudstaal PJ, Tiemeier H, Ikram MA: Anxiety is not associated with the risk of dementia or cognitive decline: the Rotterdam Study. Am J Geriatr Psychiatry 2014; 22: 1382–1390.
28.
Bierman EJM, Comijs HC, Jonker C, Beekman ATF: Symptoms of anxiety and depression in the course of cognitive decline. Dement Geriatr Cogn Disord 2007; 24: 213–219.
29.
Bakkane Bendixen A, Hartberg CB, Selbæk G, Engedal K: Symptoms of anxiety in older adults with depression, dementia, or psychosis: a principal component analysis of the Geriatric Anxiety Inventory. Dement Geriatr Cogn Disord 2016; 42: 310–322.
30.
Pachana NA, Byrne GJ, Siddle H, Koloski N, Harley E, Arnold E: Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr 2007; 19: 103–114.
31.
Pachana NA, Byrne G: The Geriatric Anxiety Inventory: international use and future directions. Aust Psychol 2012; 47: 33–38.
32.
Montgomery SA, Aasberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.
33.
Engedal K, Kvaal K, Korsnes M, Barca ML, Borza T, Selbaek G, Aakhus E: The validity of the Montgomery-Aasberg depression rating scale as a screening tool for depression in later life. J Affect Disord 2012; 141: 227–232.
34.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell scale for depression in dementia. Biol Psychiatry 1988; 23: 271–284.
35.
Barca ML, Engedal K, Selbæk G: A reliability and validity study of the Cornell scale among elderly inpatients, using various clinical criteria. Dement Geriatr Cogn Disord 2010; 29: 438–447.
36.
Knapskog A-B, Barca ML, Engedal K: Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia. Aging Ment Health 2014; 18: 579–587.
37.
Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
38.
Engedal K, Haugen P, Gilje K, Laake P: Efficacy of short mental tests in the detection of mental impairment in old age. Compr Gerontol A 1988; 2: 87–93.
39.
Shulman KI: Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000; 15: 548–561.
40.
Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–186.
41.
Lyketsos CG, Galik E, Steele C, Steinberg M, Rosenblatt A, Warren A, Sheppard JM, Baker A, Brandt J: The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc 1999; 47: 487–491.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.